i2 Analytical announcement on the current COVID-19 pandemic
UPDATE: 2nd October 2020
Message from Les Jones, CEO, i2 Analytical
Along with the rest of the UK, we have been keeping a close eye on the recent news surrounding the coronavirus (COVID-19) pandemic. Specifically, we are focused on keeping our employees, families, clients and vendors safe, while ensuring we have the right resources and capacity (logistics, customer services, technical resource) in place to keep our service delivery fully optimised. I want to take a moment to share these safeguards with you.
The i2 Analytical business continuity plan, which includes specific guidelines to the increasing infection rates we are seeing and the need to potentially lockdown (currently assessed regionally), are continuously reviewed to ensure clients will not experience any disruptions in daily business operations. We have been in contact with our key vendors and are confident that their contingency plans will also not impact our ability to provide continuous service. Our extended UK and mainland European logistics plans are sufficiently robust and flexible to ensure we are able to collect and deliver samples in a timely manner to the laboratory.
In addition, our employees have all been carefully instructed, trained and carry out best H&S practices according to current legislative guidelines.
As we navigate these times of unprecedented uncertainty, I want to assure you that our staff are 100% committed to achieving seamless continuity in maintaining the highest level of service to our customers, this is our absolute primary focus.
On behalf of all the i2 group of laboratory services, we wish you, your family and your employees good health and safety in the days and weeks ahead. We will continue to actively monitor this situation and notify you immediately of any necessary updates.
CEO i2 Analytical